v3.4.0.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Cash flows from operating activities    
Net loss $ (35,611,748) $ (2,325,695)
Adjustments to reconcile net loss to net cash used in operating activities    
Accretion of discount on notes payable 1,858,675 0
Amortization of debt issuance costs 214,958 0
Change in allowance for sales refunds 1,493,106 (178,299)
Change in allowance for uncollectible accounts 151,026 (15,274)
Change in inventory allowance 794,485 0
Depreciation and amortization 601,900 25,137
Gain on warrant revaluation (1,037,108) 0
Impairment loss on goodwill 19,177,171 0
Impairment loss on other intangible assets 2,793,415 0
Loss on inventory deposit 200,000 0
Loss on note receivable 1,035,256 0
Share-based compensation expense 362,966 599,058
Changes in operating assets and liabilities    
Accounts receivable 22,788 1,318,021
Inventories (3,743,274) (54,529)
Prepaid expenses and other current assets (939,839) (815,126)
Accounts payable 3,177,853 (779,626)
Accrued expenses and other current liabilities 1,682,586 36,991
Deferred revenue 71,198 (159,840)
Other (2,000) (10,095)
Net cash used in operating activities (7,696,586) (2,359,277)
Cash flows from investing activities    
Decrease in restricted cash 15,619 0
Cash acquired in connection with acquisitions 150,398 0
Purchase of property and equipment (275,730) 0
Net cash provided by investing activities (109,713) 0
Cash flows from financing activities    
Capital contribution from Infusion Brands International 31,162 0
Funds borrowed from affliated entities 0 2,857,207
Net payments made on accounts receivable factoring arrangement (473,861) (786,626)
Principal payments on notes payable (151,050) 0
Proceeds from senior secured note payable 8,406,833 0
Net cash provided by financing activities 7,813,084 2,070,581
Net increase (decrease) in cash 6,785 (288,696)
Cash at beginning of year 91,397 288,779
Cash at end of year 98,182 83
Supplemental Cash Flow Information    
Cash paid for interest   238,185
Cash paid for income taxes   0
Non Cash Investing and Financing Activities    
Capital contribution from Infusion Brands International   0
Common shares issued in connection with merger 5,997,476 0
Warrants issued with notes payable   0
Reclassification of accrued interest to principal balance of debt   0
Insurance premiums financed through note payable   0
Assumed note payable $ 102,500 0
Anti-dilutive shares issued   $ 0